The therapeutic categories most affected include immunosuppressants, GLP-1 agonists for diabetes and obesity, respiratory biologics, and multiple sclerosis agents precisely the categories where manufacturers have the highest revenue concentration and where biosimilar or therapeutic alternative competition is either pending or already available
doi:10.4068/cmj.2018.54.3.135
(2019) The association between low glucose-6-phosphate dehydrogenase activity level and hepatitis B virus infection among pre-pregnant reproductive-age Chinese females
The advisers voted 8-6 to add forms of the peptides KPV and TB-500 to the list, with one member abstaining
If youre starting this journey, make space for both physical and emotional care
More importantly, a recent article by Youssef et al., who investigated a small series of normal and G6PD-deficient subjects with COVID-19, highlighted a reduced survival rate among G6PD-deficient patients compared to normal ones